Dr. Harvey C. Lebos, MD

  • Savannah, GA
  • Hematologist and oncologist
NPI1962416891
Part D claims, 2017
51
Clinical trials
10
Industry payments
$1,330
State license
1
Year NPI issued
2006
Practice address
5353 Reynolds St, Savannah, GA 31405
Practice phone
Call (912) 354-6187
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Lebos' professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Harvey C. Lebos is a hematologist and oncologist in Savannah, Georgia

Dr. Lebos practices in Savannah, Georgia.

Dr. Lebos' NPI, 1962416891, was assigned on July 28, 2006. Dr. Lebos holds Georgia license 015953.

NPI and contact details
NPI enumeration date
July 28, 2006
NPI status
Active
Practice phone
(912) 354-6187
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male

Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data

Dr. Harvey C. Lebos' practice address is in Savannah, Georgia

Dr. Lebos' practice address in the NPI Registry is 5353 Reynolds St, Savannah, GA 31405, in Chatham County. The practice phone is (912) 354-6187.

  • NPI Registry address
    5353 Reynolds St, Savannah, GA 31405 · Chatham CountyPhone(912) 354-6187

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dmand AI tracks the EHR system at Dr. Harvey C. Lebos' practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lebos practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dr. Lebos' practiceAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Lebos practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Harvey C. Lebos is one of 379 hematologists and oncologists in Georgia

Hematology and oncology is Dr. Lebos' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lebos is licensed in Georgia.

Specialties and state licenses

  • Hematology and oncology, GeorgiaPrimaryLicense 015953 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Lebos

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Harvey C. Lebos' patients have a median age of 71

Across all payers, Dmand AI patient panel data puts Dr. Lebos' median patient age at 71, with 50% women.

Dr. Lebos' patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women50%
  • Men50%

Source: Dmand AI Patient Panel Data

Dr. Harvey C. Lebos wrote 51 Medicare Part D claims in 2017

In 2017, Dr. Lebos wrote 51 Medicare Part D claims. Every claim was for a generic drug. They cover 3 drugs, with $676,937 in total drug cost. In 2016, CMS named 51 claims across 3 drugs.

Part D claims, 201751
Drugs named by CMS3
Total drug cost$676,937

Dr. Lebos' most prescribed drugs by claims, 2017

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2016 to 2017

  • 2016
  • 2017
Claims for drugs CMS names
2016: 512017: 51No change

Drugs named by CMS: 3 in 2017, 3 in 2016.

See all prescribing by Dr. Lebos

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Lebos by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Harvey C. Lebos has worked on 10 clinical trials

Dmand AI links Dr. Lebos to 10 clinical trials, 4 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 4.

Clinical trials with Dr. Lebos by phase

  1. NonePhase 1: no trials
  2. 1Phase 1/2: 1 trial
  3. 1Phase 2: 1 trial
  4. 2Phase 2/3: 2 trials
  5. 4Phase 3: 4 trials
  6. NonePhase 4: no trials

Conditions in Dr. Lebos' trials

  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Bronchogenic
  • Breast Neoplasms
  • Melanoma
  • Rectal Neoplasms

Investigators on the most trials with Dr. Lebos

Recent clinical trials with Dr. Lebos

See all 10 clinical trials and co-investigators

Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage

Dr. Harvey C. Lebos received $1,330 in industry payments from 2016 to 2025

CMS Open Payments shows 84 general payments to Dr. Lebos from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Bristol-Myers Squibb Company paid the most, $216.

General payments to Dr. Lebos by program year, 2016 to 2025

General payments to Dr. Lebos by kind, 2016 to 2025

$1.3Kin total
  • Food and beverage$1,21992%
  • Education$1128%

Companies that paid Dr. Lebos the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Lebos

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Harvey C. Lebos's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
Clinical trials and co-investigatorsClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Harvey C. Lebos

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Harvey C. Lebos' NPI number?

Dr. Harvey C. Lebos' NPI number is 1962416891. It was assigned on July 28, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Harvey C. Lebos?

Dr. Harvey C. Lebos is a hematologist and oncologist in Savannah, Georgia. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Harvey C. Lebos practice?

Dr. Lebos practices at 5353 Reynolds St, Savannah, GA 31405.

What is Dr. Harvey C. Lebos' office phone number?

The practice phone on file for Dr. Lebos is (912) 354-6187.

What is Dr. Harvey C. Lebos' medical license number?

Dr. Lebos holds Georgia license 015953.

What drugs does Dr. Harvey C. Lebos prescribe most?

In 2017 Medicare Part D data, Dr. Lebos' most prescribed drugs by claims were Revlimid, Pomalyst and Tarceva.

Has Dr. Harvey C. Lebos received payments from drug or device companies?

CMS Open Payments shows $1,330 in general payments to Dr. Lebos from 22 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.

How long has Dr. Harvey C. Lebos been practicing?

Dr. Lebos' NPI was assigned in 2006.

Does Dr. Harvey C. Lebos do research?

Dr. Lebos has worked on 10 clinical trials.

Selling to hematology and oncology practices?

See hematologists and oncologists in Georgia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)